Literature DB >> 14163777

CONGENITAL ANOMALIES INDUCED IN HAMSTER EMBRYOS WITH H-1 VIRUS.

V H FERM, L KILHAM.   

Abstract

Intravenous injection of H-1 virus into pregnant hamsters early in gestation produces an embryocidal and teratogenic effect. The congenital malformations, the presence of inclusion bodies in the fetuses, and the fact that the maternal animals are not affected by this virus, are points of similarity to the teratogenic effects of rubella virus and cytomegalic-inclusion disease virus in man.

Entities:  

Keywords:  ABNORMALITIES; EXPERIMENTAL LAB STUDY; HAMSTERS; KIDNEY; LIVER; PATHOLOGY; PLACENTA; PREGNANCY; PREGNANCY, ANIMAL; SPLEEN; UTERUS; VIRUSES

Mesh：

Year:  1964        PMID： 14163777     DOI： 10.1126/science.145.3631.510

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


  6 in total

1.  Infection of newborn and fetal hamsters induced by inoculation of LuIII parvovirus.

Authors:  K F Soike; M Iatropoulis; G Siegl
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

2.  Effects of reovirus type 1 on the developing mouse embryo.

Authors:  S A Hassan; K W Cochran
Journal:  Am J Pathol       Date:  1969-04       Impact factor: 4.307

3.  Bioavailability, biodistribution, and CNS toxicity of clinical-grade parvovirus H1 after intravenous and intracerebral injection in rats.

Authors:  Karsten Geletneky; Anne-Laure Leoni; Gabriele Pohlmeyer-Esch; Stephanie Loebhard; Barbara Leuchs; Constance Hoefer; Karin Jochims; Michael Dahm; Bernard Huber; Jean Rommelaere; Ottheinz Krebs; Jacek Hajda
Journal:  Comp Med       Date:  2015-02       Impact factor: 0.982

4.  Pathology, organ distribution, and immune response after single and repeated intravenous injection of rats with clinical-grade parvovirus H1.

Authors:  Karsten Geletneky; Anne-Laure Leoni; Gabriele Pohlmeyer-Esch; Stephanie Loebhard; Andrea Baetz; Barbara Leuchs; Mandy Roscher; Constance Hoefer; Karin Jochims; Michael Dahm; Bernard Huber; Jean Rommelaere; Ottheinz Krebs; Jacek Hajda
Journal:  Comp Med       Date:  2015-02       Impact factor: 0.982

5.  A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol.

Authors:  Jacek Hajda; Monika Lehmann; Ottheinz Krebs; Meinhard Kieser; Karsten Geletneky; Dirk Jäger; Michael Dahm; Bernard Huber; Tilman Schöning; Oliver Sedlaczek; Albrecht Stenzinger; Niels Halama; Volker Daniel; Barbara Leuchs; Assia Angelova; Jean Rommelaere; Christine E Engeland; Christoph Springfeld; Guy Ungerechts
Journal:  BMC Cancer       Date:  2017-08-29       Impact factor: 4.430

Review 6.  Intrauterine virus infections and congenital heart disease.

Authors:  J C Overall
Journal:  Am Heart J       Date:  1972-12       Impact factor: 4.749
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.